Tissue kallikrein-related peptidase 4 (KLK4), a novel biomarker in triple-negative breast cancer

Volume: 398, Issue: 10, Pages: 1151 - 1164
Published: Sep 26, 2017
Abstract
Triple-negative breast cancer (TNBC), lacking the steroid hormone receptors ER and PR and the oncoprotein HER2, is characterized by its aggressive pattern and insensitivity to endocrine and HER2-directed therapy. Human kallikrein-related peptidases KLK1-15 provide a rich source of serine protease-type biomarkers associated with tumor growth and cancer progression for a variety of malignant diseases. In this study, recombinant KLK4 protein was...
Paper Details
Title
Tissue kallikrein-related peptidase 4 (KLK4), a novel biomarker in triple-negative breast cancer
Published Date
Sep 26, 2017
Volume
398
Issue
10
Pages
1151 - 1164
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.